Evol Science Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Private

  • Employees
  • 2

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 1

Evol Science General Information

Description

Operator of a biotechnology company intended to identify and therapeutically exploit mechanisms of cancer cell resistance. The company's proteomics platform, metadata analysis, and predictive analytics develop new targeted therapies to treat various diseases such as pancreatic cancer, acquired resistance metastatic melanoma, and others, enabling doctors to make the deadly cancers survivable.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Biotechnology
Other Industries
Other Pharmaceuticals and Biotechnology
Drug Discovery
Application Software
Corporate Office
  • 8134 Seminole Street
  • Philadelphia, PA 19118
  • United States
+1 (678) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Evol Science Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Accelerator/Incubator Completed Startup
To view Evol Science’s complete valuation and funding history, request access »

Evol Science Patents

Evol Science Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3664851-A1 Combinations to treat cancer Inactive 07-Aug-2017 00000000000
US-10869879-B2 Combinations to treat cancer Active 07-Aug-2017 00000000000 0
US-20190216837-A1 Combinations to treat cancer Active 07-Aug-2017 00000000000
US-20200046749-A9 Combinations to treat cancer Active 07-Aug-2017 00000000000
AU-2018313111-A1 Combinations to treat cancer Inactive 07-Aug-2017 A61K31/7068
To view Evol Science’s complete patent history, request access »

Evol Science Executive Team (3)

Name Title Board Seat Contact Info
Vikram Bhattacharjee Co-Founder & Primary Scientist
You’re viewing 1 of 3 executive team members. Get the full list »

Evol Science Board Members (1)

Name Representing Role Since
Michael Lark Self Board Member 000 0000
To view Evol Science’s complete board members history, request access »

Evol Science Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Evol Science Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Science Center Accelerator/Incubator 000 0000 000000 0
To view Evol Science’s complete investors history, request access »

Evol Science FAQs

  • When was Evol Science founded?

    Evol Science was founded in 2014.

  • Who is the founder of Evol Science?

    Joseph Driscoll, Vikram Bhattacharjee, and Andy Andrews Ph.D are the founders of Evol Science.

  • Where is Evol Science headquartered?

    Evol Science is headquartered in Philadelphia, PA.

  • What is the size of Evol Science?

    Evol Science has 2 total employees.

  • What industry is Evol Science in?

    Evol Science’s primary industry is Biotechnology.

  • Is Evol Science a private or public company?

    Evol Science is a Private company.

  • What is Evol Science’s current revenue?

    The current revenue for Evol Science is 000000.

  • Who are Evol Science’s investors?

    Science Center has invested in Evol Science.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »